The newly identified grdA gene confers high-level plazomicin resistance in Salmonella enterica serovars
Antimicrobial Agents and Chemotherapy · 2025
DOI: 10.1128/aac.01606-24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2025. Verfasst von Ahmed F Hikal und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Microbiology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, Arkansas, USA. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Salmonella enterica, Sisomicin, Bacterial Proteins. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: U.S. Food and Drug Administration.
Abstract (Originalsprache)
Plazomicin, a next-generation aminoglycoside, was recently approved by the U.S. Food and Drug Administration for the treatment of multidrug-resistant complicated urinary tract infections. It is highly effective against most aminoglycoside-modifying enzymes (AMEs). Here, we report that Salmonella enterica strains containing the newly identified gentamicin resistance gene ( grdA ) are highly resistant to plazomicin. Heterologous expression of grdA in Escherichia coli Δ tolC resulted in plazomicin resistance with minimum inhibitory concentration (MIC) > 256 µg/mL. These findings reveal that GrdA confers significantly higher resistance to plazomicin than the previously known plazomicin-resistant AMEs AA (2)-Ia and APH (2″)-Iva.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Microbiology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, Arkansas, USA.
- Office of Applied Science, Center for Veterinary Medicine, U.S. Food and Drug Administration, Laurel, Maryland, USA.
ORCID-Profile: Ahmed F Hikal, Steven Foley, Ashraf A Khan
Förderung
- U.S. Food and Drug Administration
Zitieren
APA
Hikal, A. F., Zhao, S., Foley, S., & Khan, A. A. (2025). The newly identified grdA gene confers high-level plazomicin resistance in Salmonella enterica serovars. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01606-24
Vancouver
Hikal AF, Zhao S, Foley S, Khan AA. The newly identified grdA gene confers high-level plazomicin resistance in Salmonella enterica serovars. Antimicrobial Agents and Chemotherapy. 2025. doi:10.1128/aac.01606-24
BibTeX
@article{Hikal2025,
author = {Hikal, Ahmed F and Zhao, Shaohua and Foley, Steven and Khan, Ashraf A},
title = {The newly identified grdA gene confers high-level plazomicin resistance in Salmonella enterica serovars},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2025},
doi = {10.1128/aac.01606-24}
}
EUVIMED